March 2, 2021
UT Health San Antonio and its Mays Cancer Center will receive a $6 million award from the Cancer Prevention and Research Institute of Texas to recruit Alexander Mazin, PhD, a senior, highly accomplished biochemist and cancer biologist currently at Drexel University College of Medicine.
January 19, 2021
An article published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association cites decades of published scientific evidence to make a compelling case for SARS-CoV-2’s expected long-term effects on the brain and nervous system.
January 7, 2021
San Antonians will have the opportunity to participate in the fifth international COVID-19 vaccine clinical trial beginning in January. Locally, 500 participants are being sought.
December 22, 2020
In a new paper, researchers from UT Health San Antonio report brain chemistry that may contribute to why drinkers have difficulty paying attention while under the influence.
December 3, 2020
Through this initiative, families throughout Texas will have access to vital brain donation services and researchers will be able to diagnose numerous neurodegenerative disorders using brain autopsy tissue.
November 20, 2020
PREVENTABLE clinical trial at UT Health San Antonio recruiting 450 volunteers.
November 6, 2020
The Department of Emergency Medicine in the Joe R. and Teresa Lozano Long School of Medicine has released the latest issue of its research newsletter. Check out the November 2020 issue
October 22, 2020
Scientists laid out the framework for a new COVID-19 drug design that blocks the virus from replicating and disabling human proteins crucial to the immune response.
October 15, 2020
The discovery is expected to be a springboard for future development of novel drugs to treat cardiovascular disease, metabolic disorders such as diabetes and other diseases.
October 9, 2020
Mingjiang Xu, MD, PhD, professor of molecular medicine, was awarded a $1 million UT System Faculty STARs award to enhance cancer epigenetics research and support the discovery of targeted therapeutics for blood cancers.